TEAM.NASDAQAtlassian CORP

Form 4: Atlassian CEO Michael Cannon-Brookes Executes Stock Sales Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


Atlassian CEO Michael Cannon-Brookes sold shares of Class A Common Stock on March 12, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Michael Cannon-Brookes, CEO and Co-Founder of Atlassian Corp, executed multiple sales of Class A Common Stock on March 12, 2025.
  • These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on February 8, 2024.
  • The sales were executed at varying prices, with weighted-average prices ranging from $225.1541 to $232.48 per share.
  • The total number of shares sold directly was 8,248.
  • Following these transactions, Cannon-Brookes continues to beneficially own shares both directly and indirectly through a trust.
  • The indirect holdings are through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock sales under a pre-existing trading plan, which is a routine activity.

Industry Context

Executive stock sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares over time while avoiding accusations of trading on inside information. The market typically analyzes these sales in the context of the executive's overall holdings and the company's performance.

Stakeholder Impact

  • The stock sales may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
  • The sales do not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
February 8, 2024Date the Rule 10b5-1 trading plan was adopted by the Reporting Person
March 12, 2025Date of the stock sale transactions
March 13, 2025Date of the signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.